Kupryjańczyk, J., Mądry, R., Plisiecka-Hałasa, J., Bar, J., Kraszewska, E., Ziółkowska, I., . . . Markowska, J. (2004). TP53 status determines clinical significance of ERBB2 expression in ovarian cancer. Nature Publishing Group.
Citação norma ChicagoKupryjańczyk, J., et al. TP53 Status Determines Clinical Significance of ERBB2 Expression in Ovarian Cancer. Nature Publishing Group, 2004.
MLA citiranjeKupryjańczyk, J., et al. TP53 Status Determines Clinical Significance of ERBB2 Expression in Ovarian Cancer. Nature Publishing Group, 2004.
Opozorilo: Ti citati niso vedno 100% točni.